title: Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
authors.forename: Brooke
authors.initials: B
authors.lastname: Ratliff
authors.forename: Eric C
authors.initials: EC
authors.lastname: Dietze
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Bean
authors.forename: Cassandra
authors.initials: C
authors.lastname: Moore
authors.forename: Sam
authors.initials: S
authors.lastname: Wanko
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Seewaldt
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000008:administration & dosage* / Q000494:pharmacology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D013629:Tamoxifen / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000097:blood* / Q000493:pharmacokinetics
chemical_list: D018687:Antidepressive Agents, Second-Generation; D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D013629:Tamoxifen; C016601:afimoxifene; C028787:N-desmethyltamoxifen